Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β
Robert M. Koffie(Massachusetts General Hospital), Tara L. Spires‐Jones(UK Dementia Research Institute), Hwan‐Ching Tai(Xiamen University), Virginia M. Lee(University of Pennsylvania), Kevin R. Kay(Harvard University), Alberto Serrano‐Pozo(Harvard University), Daniel Joyner(Harvard University), Tadafumi Hashimoto(Kyushu University), Bradley T. Hyman(Harvard University), Steven S. Hou(Harvard University), Matthew P. Frosch(Harvard University), David M. Holtzman(Hope Center for Neurological Disorders), Katherine J. Kopeikina(Northwestern University)
Cited by 338
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
|NeuroImage|2006|14.1k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k